More than a decade after coining “Treat Yo’ Self Day” in her role as Donna on “Parks & Recreation,” Retta is once again ...

As a leading CGM maker, DexCom is likely to play a significant role in diabetes care for years, possibly decades. Given all ...

Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

Now, people without health insurance coverage for such devices have the option to buy Stelo directly from Dexcom’s website ... of a single pack with two sensors — which lasts 30 days ...

Patients could buy a pack of two sensors at a one-time price of $99 or opt for a subscription to get a monthly delivery for $89, Dexcom said. Abbott had said it plans to launch Lingo in the U.S ...

Stock analysis is all about predictions – but as wits from Mark Twain to Yogi Berra have reminded us, predictions are hard, ...

New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.

JPMorgan reduced its rating on Dexcom's shares from buy to hold, noting the ... increased adoption of its continuous glucose ...

William Plovanic has given his Buy rating due to a combination of factors surrounding Dexcom’s strategic position ... the first over-the-counter glucose sensor in the US designed for a broad ...

As a leading CGM maker, DexCom is likely to play a significant role in diabetes care for years, possibly decades. Given all that growth potential, the healthcare stock looks like a no-brainer buy ...